Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 214836, 10 pages
http://dx.doi.org/10.1155/2015/214836
Research Article

EGCG Attenuates Uric Acid-Induced Inflammatory and Oxidative Stress Responses by Medicating the NOTCH Pathway

Nutrition Department, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China

Received 25 March 2015; Accepted 1 July 2015

Academic Editor: Gagan Deep

Copyright © 2015 Hua Xie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U. M. Khosla, S. Zharikov, J. L. Finch et al., “Hyperuricemia induces endothelial dysfunction,” Kidney International, vol. 67, no. 5, pp. 1739–1742, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. L. Rock, H. Kataoka, and J.-J. Lai, “Uric acid as a danger signal in gout and its comorbidities,” Nature Reviews Rheumatology, vol. 9, no. 1, pp. 13–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. T. Emmerson, “Identification of the causes of persistent hyperuricaemia,” The Lancet, vol. 337, no. 8755, pp. 1461–1463, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Krstić, D. Trivanović, S. Mojsilović, and J. F. Santibanez, “Transforming growth factor-beta and oxidative stress interplay: implications in tumorigenesis and cancer progression,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 654594, 15 pages, 2015. View at Publisher · View at Google Scholar
  5. L. C. Price, S. J. Wort, F. Perros et al., “Inflammation in pulmonary arterial hypertension,” Chest, vol. 141, no. 1, pp. 210–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Chamarthi, G. H. Williams, V. Ricchiuti et al., “Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans,” The American Journal of Hypertension, vol. 24, no. 10, pp. 1143–1148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Sadat, F. A. Jaffer, M. A. M. J. van Zandvoort, S. J. Nicholls, D. Ribatti, and J. H. Gillard, “Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets,” Circulation, vol. 130, no. 9, pp. 786–794, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Patel and M. A. Blazing, “Inflammation and atherosclerosis: disease modulating therapies,” Current Treatment Options in Cardiovascular Medicine, vol. 15, no. 6, pp. 681–695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. C. Hasselbalch, “Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?” Blood, vol. 119, no. 14, pp. 3219–3225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Y. Donath, É. Dalmas, N. S. Sauter, and M. Böni-Schnetzler, “Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity,” Cell Metabolism, vol. 17, no. 6, pp. 860–872, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. PS. Tucker and AT. Scanlan, Dalbo VJ: Chronic kidney disease influences multiple systems: Describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Oxid Med Cell Longev, 2015, 806358, 2015.
  12. K. Takeshita, M. Satoh, M. Ii et al., “Critical role of endothelial Notch1 signaling in postnatal angiogenesis,” Circulation Research, vol. 100, no. 1, pp. 70–78, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. Marchant, J. H. Boyd, D. C. Lin, D. J. Granville, F. S. Garmaroudi, and B. M. McManus, “Inflammation in myocardial diseases,” Circulation Research, vol. 110, no. 1, pp. 126–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Fischer and O. Maier, “Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 610813, 18 pages, 2015. View at Publisher · View at Google Scholar
  15. A. Croquelois, A. A. Domenighetti, M. Nemir et al., “Control of the adaptive response of the heart to stress via the Notchl receptor pathway,” The Journal of Experimental Medicine, vol. 205, no. 13, pp. 3173–3185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Kratsios, C. Catela, E. Salimova et al., “Distinct roles for cell-autonomous notch signaling in cardiomyocytes of the embryonic and adult heart,” Circulation Research, vol. 106, no. 3, pp. 559–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Li, K. Takeshita, P.-Y. Liu et al., “Smooth muscle notch1 mediates neointimal formation after vascular injury,” Circulation, vol. 119, no. 20, pp. 2686–2692, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. N. Singh, B. R. Singh, R. L. Singh et al., “Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera,” Food and Chemical Toxicology, vol. 47, no. 6, pp. 1109–1116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. B. N. Singh, S. Shankar, and R. K. Srivastava, “Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications,” Biochemical Pharmacology, vol. 82, no. 12, pp. 1807–1821, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. An, Y. Qi, D. Huang et al., “EGCG inhibits Cd2+-induced apoptosis through scavenging ROS rather than chelating Cd2+ in HL-7702 cells,” Toxicology Mechanisms and Methods, vol. 24, no. 4, pp. 259–267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-W. Chang, Y.-H. Hsieh, W.-E. Yang, S.-F. Yang, Y. Chen, and D.-N. Hu, “Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway,” BioMed Research International, vol. 2014, Article ID 141582, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-R. Hsieh, C.-S. Hsu, C.-H. Lu, W.-C. Chen, C.-H. Chiu, and Y.-M. Liou, “Epigallocatechin-3-gallate-mediated cardioprotection by Akt/GSK-3β/caveolin signalling in H9c2 rat cardiomyoblasts,” Journal of Biomedical Science, vol. 20, article 86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Adikesavan, M. M. Vinayagam, L. A. Abdulrahman, and T. Chinnasamy, “(-)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats,” Molecular Biology Reports, vol. 40, no. 12, pp. 6533–6545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. T. Devika and P. S. M. Prince, “Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats,” Chemico-Biological Interactions, vol. 172, no. 3, pp. 245–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Yang, Y. Han, C. Chen et al., “EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-κB signaling in human umbilical vein endothelial cells,” Life Sciences, vol. 92, no. 10, pp. 589–597, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Jin, W. Gong, C. Zhang, and S. Wang, “Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling,” OncoTargets and Therapy, vol. 6, pp. 145–153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D.-H. Kang, S.-K. Park, I.-K. Lee, and R. J. Johnson, “Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells,” Journal of the American Society of Nephrology, vol. 16, no. 12, pp. 3553–3562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. S. Park, J. N. Chun, H. Y. Jung, C. Choi, and Y. S. Bae, “Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells,” Cardiovascular Research, vol. 72, no. 3, pp. 447–455, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Rusanescu, R. Weissleder, and E. Aikawa, “Notch signaling in cardiovascular disease and calcification,” Current Cardiology Reviews, vol. 4, no. 3, pp. 148–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Jatuworapruk, S. Srichairatanakool, S. Ounjaijean, N. Kasitanon, S. Wangkaew, and W. Louthrenoo, “Effects of green tea extract on serum uric acid and urate clearance in healthy individuals,” Journal of Clinical Rheumatology, vol. 20, no. 6, pp. 310–313, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Quillard and B. Charreau, “Impact of notch signaling on inflammatory responses in cardiovascular disorders,” International Journal of Molecular Sciences, vol. 14, no. 4, pp. 6863–6888, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-C. Chen, S.-R. Hsieh, C.-H. Chiu, B.-D. Hsu, and Y.-M. Liou, “Molecular identification for epigallocatechin-3-gallate-mediated antioxidant intervention on the H2O2-induced oxidative stress in H9c2 rat cardiomyoblasts,” Journal of Biomedical Science, vol. 21, no. 1, article 56, 2014. View at Publisher · View at Google Scholar · View at Scopus